Search scope:
排序: Display mode:
Developing effective tumor vaccines: basis, challenges and perspectives
XU Qingwen, CHEN Weifeng
Frontiers of Medicine 2007, Volume 1, Issue 1, Pages 11-19 doi: 10.1007/s11684-007-0003-9
Keywords: development conventional identification elucidation Successful immunotherapy
Prospects of immunotherapy for cancer
Zhinan Chen
Frontiers of Medicine 2019, Volume 13, Issue 1, Pages 1-2 doi: 10.1007/s11684-019-0691-y
Immunometabolism: a new dimension in immunotherapy resistance
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 585-616 doi: 10.1007/s11684-023-1012-z
Keywords: immune cell immunometabolism metabolic reprogramming immunotherapy resistance tumor microenvironment
Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine
Hongmei Xu, Xuetao Cao
Frontiers of Medicine 2011, Volume 5, Issue 4, Pages 323-332 doi: 10.1007/s11684-011-0172-4
Challenges of NK cell-based immunotherapy in the new era
Fang Fang, Weihua Xiao, Zhigang Tian
Frontiers of Medicine 2018, Volume 12, Issue 4, Pages 440-450 doi: tzg@ustc.edu.cn
Natural killer cells (NKs) have a great potential for cancer immunotherapy because they can rapidly
Keywords: natural killer cells immunotherapy adoptive transfer genetic modification immune checkpoint inhibitor
Frontiers of Engineering Management 2022, Volume 9, Issue 1, Pages 159-162 doi: 10.1007/s42524-021-0183-z
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies
Frontiers of Medicine 2021, Volume 15, Issue 6, Pages 783-804 doi: 10.1007/s11684-021-0904-z
Keywords: CAR T cells hematological malignancies review
The dawn of successful prediction of major earthquakes
Li Ping and Yang Mei’e
Strategic Study of CAE 2009, Volume 11, Issue 6, Pages 19-27
Keywords: Wenchuan Earthquake strong earthquake prediction microseism generating fault
Cybersecurity Research—Essential to a Successful Digital Future
Jackie Craig
Engineering 2018, Volume 4, Issue 1, Pages 9-10 doi: 10.1016/j.eng.2018.02.006
Functional tolerance theory in incremental growth design
YANG Bo, ZE Xiangbo, YANG Tao
Frontiers of Mechanical Engineering 2007, Volume 2, Issue 3, Pages 336-343 doi: 10.1007/s11465-007-0059-x
Keywords: successful transformation mathematical automation technology tolerance allocation minimum
Qinghua HE, Junyan XU, Ting WANG, Albert P. C. CHAN
Frontiers of Engineering Management 2021, Volume 8, Issue 1, Pages 5-16 doi: 10.1007/s42524-019-0058-8
Keywords: megaproject management driving factors project success case study China
Regulatory T Cells and Their Clinical Applications in Antitumor Immunotherapy Review
Feng Xie, Rui Liang, Dan Li, Bin Li
Engineering 2019, Volume 5, Issue 1, Pages 132-139 doi: 10.1016/j.eng.2018.12.002
Keywords: Regulatory T cells Cancer Immunotherapy
Chuangnian Zhang, Ying Dong, Jing Gao, Xiaoli Wang, Yanjun Jiang
Frontiers of Chemical Science and Engineering 2021, Volume 15, Issue 5, Pages 1296-1311 doi: 10.1007/s11705-020-2034-6
Keywords: silica nanoflower antigen delivery cancer immunotherapy nanovaccine
Frontiers of Medicine 2022, Volume 16, Issue 1, Pages 139-149 doi: 10.1007/s11684-021-0835-8
Keywords: B-cell acute lymphoblastic leukemia bispecific antibody trispecific antibody CD19 CD20
Activation of phagocytosis by immune checkpoint blockade
Chia-Wei Li, Yun-Ju Lai, Jennifer L. Hsu, Mien-Chie Hung
Frontiers of Medicine 2018, Volume 12, Issue 4, Pages 473-480 doi: 10.1007/s11684-018-0657-5
Inhibition of macrophage-mediated phagocytosis has emerged as an essential mechanism for tumor immune evasion. One mechanism inhibiting the innate response is the presence of the macrophage inhibitory molecule, signal regulatory protein-α (SIRPα), on tumor-associated macrophages (TAMs) and its cognate ligand cluster of differentiation 47 (CD47) on tumor cells in the tumor microenvironment. On the basis of a recently discovered programmed death protein 1 (PD-1) in TAMs, we discuss the potential inhibitory receptors that possess new functions beyond T cell exhaustion in this review. As more and more immune receptors are found to be expressed on TAMs, the corresponding therapies may also stimulate macrophages for phagocytosis and thereby provide extra anti-tumor benefits in cancer therapy. Therefore, identification of biomarkers and combinatorial therapeutic strategies, have the potential to improve the efficacy and safety profiles of current immunotherapies.
Keywords: CD47 PD-1 PD-L1 immunotherapy TAM phagocytosis macrophage
Title Author Date Type Operation
Developing effective tumor vaccines: basis, challenges and perspectives
XU Qingwen, CHEN Weifeng
Journal Article
Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine
Hongmei Xu, Xuetao Cao
Journal Article
Challenges of NK cell-based immunotherapy in the new era
Fang Fang, Weihua Xiao, Zhigang Tian
Journal Article
Engineers as business leaders: A need to investigate formative collegiate experiences of highly successful
Journal Article
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignancies
Journal Article
Functional tolerance theory in incremental growth design
YANG Bo, ZE Xiangbo, YANG Tao
Journal Article
Identifying the driving factors of successful megaproject construction management: Findings from three
Qinghua HE, Junyan XU, Ting WANG, Albert P. C. CHAN
Journal Article
Regulatory T Cells and Their Clinical Applications in Antitumor Immunotherapy
Feng Xie, Rui Liang, Dan Li, Bin Li
Journal Article
and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy
Journal Article